PTGS2 and neoplasm: Both pathways activate key transcription factors, primarily nuclear factor -kB, signal transducer and activator of transcription 3, and HIF1α in tumor cells, which in turn lead to inflammatory mediators and cyclooxygenase-2 being produced, resulting in cancer-related inflammation and further promotion of tumor progression [7].